Cerus (CERS) Net Margin Growth (5y) (2015 - 2026)
Cerus (CERS) Net Margin Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Cerus | 562.58 Mn | 506.32 Mn | 29.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4,360.00 |
| Mar 31, 2026 | 17,757.00 |
| Dec 31, 2025 | 185.00 |
| Sep 30, 2025 | 229,876.00 |
| Jun 30, 2025 | -94,196.00 |
| Mar 31, 2025 | 522,610.00 |
| Dec 31, 2024 | 4,589.00 |
| Sep 30, 2024 | 384,614.00 |
| Jun 30, 2024 | 39,249.00 |
| Mar 31, 2024 | 38,766.00 |
| Dec 31, 2023 | 9,732.00 |
| Sep 30, 2023 | -407,127.00 |
| Jun 30, 2023 | 29,388.00 |
| Mar 31, 2023 | -913.00 |
| Dec 31, 2022 | 54,355.00 |
| Sep 30, 2022 | -155.00 |
| Jun 30, 2022 | 100,430.00 |
| Mar 31, 2022 | 18,247.00 |
| Dec 31, 2021 | 13,530.00 |
| Sep 30, 2021 | -6,704.00 |